Histone Methylation and Transcriptional Regulation in Cardiovascular Disease

ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)

Volume 15, 3 Issues, 2015

Download PDF Flyer

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Garry X. Shen
University of Manitoba
Winnipeg, MB

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Histone Methylation and Transcriptional Regulation in Cardiovascular Disease

Cardiovascular & Hematological Disorders-Drug Targets, 14(2): 89-97.

Author(s): Yong Xu and Fei Fang.

Affiliation: 140 Hanzhong Rd, Nanjing, Jiangsu 210029, China.


Cardiovascular disease (CVD) represents a major health risk to the global population. In disease settings, cells that constitute the vasculature undergo profound changes both morphologically and functionally paralleling alterations in gene expression profile. At the transcriptional level, gene expression is steered by the epigenetic machinery including DNA methyltransferases, histone variants, non-coding regulatory RNAs, chromatin remodeling complexes, and histone modifying enzymes. The N-terminal tails of histones, primarily histones H3 and H4, are post-translationally modified creating a unique platform for transcriptional regulation. This review summarizes our current understanding of the role of histone methylation in modulating the vascular transcriptome and its relevance in CVD with an outlook on future directions.


Cardiovascular disease, epigenetics, histone methylation, transcriptional regulation.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 2
First Page: 89
Last Page: 97
Page Count: 9
DOI: 10.2174/1871529X14666140505122144

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science